CORVEL Posts Strong 10.2% Revenue Growth, Net Income Jumps 15.5%
Ticker: CRVL · Form: 10-K · Filed: May 23, 2025 · CIK: 874866
| Field | Detail |
|---|---|
| Company | Corvel CORP (CRVL) |
| Form Type | 10-K |
| Filed Date | May 23, 2025 |
| Risk Level | medium |
| Sentiment | bullish |
Sentiment: bullish
Topics: Workers' Compensation, Insurance Services, Revenue Growth, Net Income Growth, Share Repurchase, Healthcare Services, Risk Management
Related Tickers: CRVL
TL;DR
**CRVL is a buy, as its consistent double-digit growth in a stable industry makes it a reliable performer.**
AI Summary
CORVEL CORP reported robust financial performance for the fiscal year ended March 31, 2025, with significant growth in revenue and net income. The company's net sales from Patient Management Services, a key segment, were $698.7 million for the year ended March 31, 2025, up from $635.4 million in the prior year, representing a 9.96% increase. Overall revenue increased by 10.2% to $705.1 million in fiscal 2025 from $640.0 million in fiscal 2024. Net income attributable to CORVEL CORP shareholders rose by 15.5% to $98.5 million in fiscal 2025, compared to $85.3 million in fiscal 2024. The company continued its share repurchase program, buying back $25.0 million of common stock during the fiscal year. Strategic outlook emphasizes continued investment in technology and service expansion, while key risks include intense competition in the workers' compensation and auto liability markets, and potential impacts from healthcare regulatory changes.
Why It Matters
CORVEL's strong financial performance, particularly the 10.2% revenue increase and 15.5% net income jump, signals healthy demand for its workers' compensation and auto liability services, which is positive for investors. This growth, driven by its Patient Management Services, demonstrates the company's ability to navigate a competitive landscape against rivals like Optum and Sedgwick. For employees, continued expansion and profitability could mean job security and growth opportunities. Customers benefit from a stable and growing service provider, while the broader market sees a resilient player in the insurance services sector, potentially influencing industry benchmarks and innovation.
Risk Assessment
Risk Level: medium — The risk level is medium due to significant competition in the workers' compensation and auto liability markets, as highlighted by the company's disclosure of intense competition. While CORVEL shows strong growth, its reliance on a few key service lines, particularly Patient Management Services which accounts for over 99% of revenue, could expose it to market shifts or increased competitive pressures.
Analyst Insight
Investors should consider adding CRVL to their portfolios, given its consistent revenue and net income growth, particularly the 15.5% increase in net income to $98.5 million. Monitor competitive dynamics and any potential regulatory changes in the healthcare and insurance sectors, as these could impact future performance.
Financial Highlights
- revenue
- $705.1M
- net Income
- $98.5M
- revenue Growth
- +10.2%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Patient Management Services | $698.7M | +9.96% |
Key Numbers
- $705.1M — Total Revenue (Increased 10.2% from $640.0M in fiscal 2024.)
- $98.5M — Net Income (Increased 15.5% from $85.3M in fiscal 2024.)
- $698.7M — Patient Management Services Revenue (Represents over 99% of total revenue, up from $635.4M.)
- 10.2% — Revenue Growth (Year-over-year increase in total revenue.)
- 15.5% — Net Income Growth (Year-over-year increase in net income.)
- $25.0M — Share Repurchases (Amount of common stock repurchased in fiscal 2025.)
Key Players & Entities
- CORVEL CORP (company) — filer of the 10-K
- Patient Management Services (company) — primary revenue-generating segment
- $705.1 million (dollar_amount) — total revenue for fiscal year 2025
- $640.0 million (dollar_amount) — total revenue for fiscal year 2024
- $98.5 million (dollar_amount) — net income for fiscal year 2025
- $85.3 million (dollar_amount) — net income for fiscal year 2024
- 10.2% (dollar_amount) — revenue growth percentage
- 15.5% (dollar_amount) — net income growth percentage
- $25.0 million (dollar_amount) — common stock repurchased during fiscal year 2025
- March 31, 2025 (date) — end of the fiscal year
FAQ
What were CORVEL CORP's total revenues for the fiscal year ended March 31, 2025?
CORVEL CORP reported total revenues of $705.1 million for the fiscal year ended March 31, 2025, marking a 10.2% increase from the $640.0 million reported in the prior fiscal year.
How much did CORVEL CORP's net income increase in fiscal year 2025?
Net income attributable to CORVEL CORP shareholders increased by 15.5% to $98.5 million for the fiscal year ended March 31, 2025, up from $85.3 million in fiscal year 2024.
What is the primary source of CORVEL CORP's revenue?
The primary source of CORVEL CORP's revenue is Patient Management Services, which generated $698.7 million for the fiscal year ended March 31, 2025, representing over 99% of total revenue.
Did CORVEL CORP engage in any share repurchase programs during fiscal 2025?
Yes, CORVEL CORP repurchased $25.0 million of its common stock during the fiscal year ended March 31, 2025, under its ongoing share repurchase program.
What are the key risks identified by CORVEL CORP in its 10-K filing?
Key risks include intense competition in the workers' compensation and auto liability markets, and potential impacts from healthcare regulatory changes, which could affect the company's operational and financial performance.
How does CORVEL CORP's revenue growth compare to the previous fiscal year?
CORVEL CORP's revenue grew by 10.2% to $705.1 million in fiscal 2025, which is a strong acceleration compared to previous periods, demonstrating robust market demand for its services.
What is CORVEL CORP's strategic outlook for future growth?
CORVEL CORP's strategic outlook emphasizes continued investment in technology and service expansion to maintain its competitive edge and drive further growth in its core Patient Management Services segment.
What was the revenue from Patient Management Services for CORVEL CORP in fiscal year 2024?
Revenue from Patient Management Services for CORVEL CORP in fiscal year 2024 was $635.4 million, which increased to $698.7 million in fiscal year 2025.
What industry does CORVEL CORP primarily operate in?
CORVEL CORP primarily operates in the insurance agents, brokers, and services industry, specifically focusing on workers' compensation and auto liability claims management.
What is the fiscal year end date for CORVEL CORP?
The fiscal year end date for CORVEL CORP is March 31, as indicated by the filing for the period ended March 31, 2025.
Risk Factors
- Intense Competition [high — market]: The company faces significant competition in the workers' compensation and auto liability markets. This intense competitive landscape could pressure pricing and market share.
- Healthcare Regulatory Changes [medium — regulatory]: Potential impacts from changes in healthcare regulations pose a risk. Evolving regulatory environments can affect service delivery, compliance costs, and overall business operations.
Industry Context
Corvel operates within the specialized insurance services sector, focusing on workers' compensation and auto liability claims management. The industry is characterized by a need for efficient claims processing, cost containment, and regulatory compliance. Key trends include the adoption of technology to streamline operations and enhance service delivery, as well as ongoing consolidation among service providers.
Regulatory Implications
The company's operations are subject to healthcare and insurance regulations, which can vary by state and jurisdiction. Changes in these regulations, particularly concerning claims handling, medical cost containment, and data privacy, could necessitate adjustments to business practices and potentially impact profitability.
What Investors Should Do
- Monitor competitive pressures in workers' compensation and auto liability markets.
- Track developments in healthcare regulatory changes.
- Evaluate the effectiveness of technology investments.
- Analyze the impact of share repurchase program on EPS.
Glossary
- Patient Management Services
- Services provided by Corvel to manage patient care, likely within the context of workers' compensation and auto liability claims. (This is the primary revenue-generating segment for Corvel, and its growth is critical to the company's overall financial performance.)
- Workers' Compensation
- A form of insurance providing wage replacement and medical benefits to employees injured in the course of employment. (This is a key market for Corvel's services, and competition and regulatory changes within this sector directly impact the company.)
- Auto Liability
- Insurance that covers damages or injuries to other people or their property caused by the insured's vehicle. (Another core market for Corvel, subject to similar competitive and regulatory pressures as workers' compensation.)
- Share Repurchases
- A company buying back its own shares from the marketplace, which can reduce the number of outstanding shares and potentially increase earnings per share. (Corvel actively engaged in share repurchases ($25.0M), indicating a strategy to return capital to shareholders and potentially boost EPS.)
Year-Over-Year Comparison
Corvel Corp. demonstrated strong year-over-year performance, with total revenue increasing by 10.2% to $705.1 million and net income growing by 15.5% to $98.5 million. The primary driver, Patient Management Services, saw a 9.96% revenue increase. While the company continued its share repurchase program, no new significant risks were highlighted in this filing compared to the previous year, suggesting a stable risk profile despite the growth.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on May 23, 2025 regarding CORVEL CORP (CRVL).